The Effect of Metabolic Syndrome Status on Lung Function and Patient-reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

Background: Concurrent chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) represent an important clinical phenotype with overlapping symptomology. The effect of MetS in COPD patients was assessed following treatment with nebulized glycopyrrolate (GLY; administered via eFlow®...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chronic Obstr Pulm Dis
Autors principals: Carlin, Brian, Ferguson, Gary T., Ozol-Godfrey, Ayca, Goodin, Thomas, Sanjar, Shahin
Format: Artigo
Idioma:Inglês
Publicat: COPD Foundation Inc 2020
Matèries:
Origianl Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7883902/
https://ncbi.nlm.nih.gov/pubmed/32822528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.7.4.2020.0145
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars